HSBC Holdings’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1,100
Closed -$224K – 3158
2025
Q3
$224K Hold
1,100
– – ﹤0.01% 2439
2025
Q2
$191K Hold
1,100
– – ﹤0.01% 2698
2025
Q1
$147K Hold
1,100
– – ﹤0.01% 2705
2024
Q4
$138K Hold
1,100
– – ﹤0.01% 2821
2024
Q3
$180K Hold
1,100
– – ﹤0.01% 2656
2024
Q2
$146K Buy
+1,100
New +$132K ﹤0.01% 2651
2023
Q1
– Sell
-19,600
Closed -$939K – 3037
2022
Q4
$939K Hold
19,600
– – ﹤0.01% 1998
2022
Q3
$1.03M Buy
+19,600
New +$1.16M ﹤0.01% 1814
2017
Q2
– Sell
-6,000
Closed -$106K – 2260
2017
Q1
$106K Sell
6,000
-144,000
-96% -$2.67M ﹤0.01% 2062
2016
Q4
$2.23M Buy
+150,000
New +$2.69M 0.01% 1187

Other funds holding THC

HSBC Holdings's THC Position: Q2 2026 in Review

HSBC Holdings increased its Tenet Healthcare (THC) stake by 11% in Q2 2026, buying an estimated $5.32M and bringing the position to 289,055 shares worth $54M. The position accounts for 0.02% of the portfolio, ranked #524.

HSBC Holdings first reported a position in THC in Q2 2013 and has held it in 53 quarters since. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • HSBC Holdings held 289,055 shares of Tenet Healthcare worth $54M as of Q2 2026.
  • HSBC Holdings bought 28,941 Tenet Healthcare shares in Q2 2026, an estimated $5.32M.
  • Tenet Healthcare made up 0.02% of HSBC Holdings's portfolio in Q2 2026, its #524 holding.
  • HSBC Holdings first reported a position in Tenet Healthcare in Q2 2013 and has held it in 53 quarters since.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.